ArticleBMC cancer2026

Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study.

Zehra Sucuoğlu İşleyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.